In a practical sense the stock is very overbought. Its share price is based solely on speculation and hope. There is no difference now regarding near term earnings than when the stock was recently trading in the $3's.
Just in is news comprised solely of a headline from The Street accompanied with absolutely no information attached to it in an article which incidentally includes an entire page of disclaimers while lacking any conviction or promise. This indicates to me that those talking heads estimate that the bottom in the energy plummet is in, but the panty waists are covering their buttocks with their recommendation which they will take credit for later. Apparently retail investors have been alerted that it is okay to load up on stocks in the energy sector. Longs should add to their positions now as the upward movement of this company stock is being bolstered.
I speak Jive and will translate what prophet7721 is trying to convey to MHR Longs. MRH is Code used between Shorts which means: My Rectum Hurts.
Today institutional managers are selling their dogs and high fliers. Next week in April this stock could attract more buyers looking for opportunities in the energy space, resulting in a run up into the $3's.
has begun as this is the end of the first quarter and after three days of selling this should conclude on Friday. Next week in April buyers will move into this company stock resulting in a healthy gain for Longs.
and this will conclude on Friday. Next week buyers will rush in scooping up shares of this promising equity and run it up into the $3's.
when the Federal Reserved removed the word 'patience' from its dialogue and therefore hinting at an interest rate increase or maybe two, with the first as early as June. Reports since then show that the economy is slowing, so there may not be any increase until sometime in 2016, if then.
It looks like possibly the early stages of a wide spread bear raid on numerous frothy valuation unproven biotechnology company stocks. Probably best to exit and reinvest in the same but lower priced beaten down choices in the sector.
This is Randal J. Kirk's baby and with Intrexon together with other smaller companies and no approval a suitor would only be buying hope.
This company stock is a honey of a contrarian in the making and at a sweet accumulation price.
Maxim Reiterates Buy on AEterna Zentaris Inc. Following 4Q:14 Update
March 19, 2015
by Ben Mahaney,
Editor in Exclusively Published
Maxim Group's healthcare analyst Jason Kolbert came out with a research note on AEterna Zentaris Inc. after the company reported its fourth-quarter financial results and provided a corporate update.
Kolbert noted, "Aeterna announced 4Q results, spending $11M in the quarter and closing the year with $35M in cash, which we add to the $47.2M the company raised (less $5.7M to extinguish outstanding warrants) in 1Q15. With a current net of ~$70M in cash, the company is well positioned to acquire commercial-stage products that fit with its female health focus. We also note that management guided to a reduced burn rate as a result of their restructured R&D effort, prolonging their cash runway."
Furthermore, "AEZS began selling EstroGel, a topical gel for hormone replacement, in December 2014. We expect to see the first launch results in 1Q15. While we believe EstroGel can be a good product we do not see it making a meaningful revenue contribution, instead we believe it helps the company build its commercial focus, setting the stage for additional product acquisitions, which, when combined, can be meaningful, or in other words Estrogel creates strategic value for the company beyond its revenue contribution."
The analyst rates the stock a Buy with a $2.00 price target, which implies an upside of 261% from current levels.
kahn_boonie: "I will accumulate more as the price drops"
wazoo_wazoo_wazoo: "You will accumulate more as the price rises".
Analyst on CNBC from Houston explaining why what fell so quickly will rise quickly, so look for recovery during the third quarter of this year to oil over $70 a barrel.